Allergan Sues Apotex Again Over Generic Pinkeye Drug

Law360, New York (November 29, 2011, 3:31 PM EST) -- Allergan Inc. and two Japanese pharmaceutical companies sued generics maker Apotex Inc. again in Delaware on Monday, alleging it has infringed a recently re-examined patent in seeking approval for a generic version of pinkeye treatment Zymar.

The suit — brought by Allergan, Senju Pharmaceuticals Co. Ltd. and Kyorin Pharmaceuticals Co. Ltd. — accuses Apotex of infringing an amended claim and several recently added claims of a patent that was re-examined this year at the request of patent owners Senju and Kyorin. It says Apotex is preparing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.